Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma
Introduction
Unlike tumors of the upper and lower third regions of the stomach, middle third gastric carcinoma is often not diagnosed until the tumor becomes bulky and metastasizes to the regional lymph nodes because there are no obvious symptoms at earlier stages.1 When the tumors advance, the lymph nodes around the splenic artery and hilum are also frequently involved.2 Several studies have reported that the incidence of lymph node metastasis is 9.7–20% along the splenic artery and 9.2–17% at the splenic hilum in advanced proximal and middle third gastric carcinoma.3, 4, 5, 6, 7
Gastrectomy with lymphadenectomy is still the best method to cure patients with gastric carcinoma. The extent of gastrectomy for advanced middle third gastric carcinoma depends on the location of the tumor, and total gastrectomy is usually performed to obtain negative margins.8 D2 lymphadenectomy is generally accepted as the standard surgery for gastric carcinoma in Japan and Korea. According to the Japanese Classification of Gastric Carcinoma,9 the lymph nodes along the distal splenic artery (No. 11d) and at the splenic hilum (No. 10) are group 3 lymph nodes for middle third gastric carcinoma. Due to the high frequency of lymph node metastasis around the splenic artery and hilum, splenectomy or spleen-preserved lymphadenectomy around the splenic artery and hilum is an important surgical consideration for patients with advanced middle third gastric cancer.6, 10, 11 However, the effect of the extended lymph node dissection and splenectomy for advanced middle third gastric carcinoma is unknown.
The purpose of this study is to evaluate both the clinicopathological factors influencing lymph node metastasis around the splenic artery and hilum and the effect of spleen-preserved lymphadenectomy in cases of advanced middle third gastric carcinoma.
Section snippets
Tumor location
According to the Japanese Classification of Gastric Carcinoma, the location of a tumor is classified as the upper, middle, or lower (U, M or L) third of the stomach longitudinally. In this study, middle third carcinoma of the stomach was defined by the tumor being located in the middle third region of the stomach (M or ML). The tumors located in LM, UM or MU were excluded from this study.
Patients
From January 2000 to December 2004, 3267 patients with gastric carcinoma underwent gastrectomy in the
Status of lymph node metastasis
The mean total number of retrieved lymph nodes was 54, and a mean number of 5.2 lymph nodes were found around the splenic artery and hilum of each specimen. The incidence of No. 10 and/or No. 11 lymph node metastasis was 31% in advanced middle third gastric carcinoma. No. 10 alone, No. 11 alone, and both Nos. 10 and 11 lymph node metastases were observed in 20, 12, and 8 patients, respectively.
Univariate analysis
In a comparison between patients with and without No. 10 and/or No. 11 lymph node metastasis, the
Metastasis of lymph node Nos. 10 and 11
Lymph node metastasis in gastric carcinoma is associated with tumor advancement. In early gastric carcinoma of the middle third of the stomach, dissection of lymph node around the splenic artery and hilum does not need to be performed because metastasis of the lymph node is not found in these areas. However, in advanced middle third gastric carcinoma, dissection of the lymph nodes around the splenic artery and hilum should be surgically considered, because 10–20% of patients undergoing extended
Conflict of interest
The authors have no conflict of interest.
Acknowledgement
This study was supported in part by a grant of the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (0412-CR01-0704-0001).
References (23)
- et al.
Prognostic significance of combined splenectomy or pancreaticosplenectomy in total and proximal gastrectomy for gastric cancer
Am J Surg
(1981) - et al.
Comparison of complications after D2 and D3 dissection for gastric cancer
Eur J Surg Oncol
(2004) - et al.
A prospective pilot study of extended (D3) and superextended para-aortic lymphadenectomy (D4) in patients with T3 or T4 gastric cancer managed by total gastrectomy
Surgery
(1999) - et al.
Standard D2 versus extended D2(D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial
Am J Surg
(2007) - et al.
Total gastrectomy with distal pancreatectomy and splenectomy for advanced gastric cancer
J Surg Res
(2001) - et al.
Selection of operative procedure for adenocarcinoma of the midstomach. Twenty years' experience with implications for future treatment strategy
Ann Surg
(1980) - et al.
Adenocarcinoma of midstomach. Clinical and pathoanatomic relation to lymph node metastases
J Clin Gastroenterol
(1994) - et al.
Lymph node metastasis at the splenic hilum in proximal gastric cancer
Am Surg
(2004) - et al.
Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus
J Surg Oncol
(2001) - et al.
Radical resection of gastric carcinoma with pancreas and spleen preservation and functional cleaning of lymph nodes
Chin Med J
(2002)
Pancreas-preserving total gastrectomy for proximal gastric cancer
World J Surg
Cited by (17)
CT-based radiomics nomogram for preoperative prediction of No.10 lymph nodes metastasis in advanced proximal gastric cancer
2021, European Journal of Surgical OncologyCitation Excerpt :A tailored surgical approach for No.10 LNs dissection may necessitate appropriate patient selection [10]. In addition, a poor prognosis is associated with No.10 LNs metastasis (LNM), and No.10 LNs should be considered as non-regional LNs in the treatment of APGC as has been reported in some studies [10],[11]. Therefore, individualized treatments, such as more intensive (neo)adjuvant therapy or postoperative surveillance to detect the relapse of No.10 LNM, would be required for APGC patients with No. 10 LNM.
Significance of lymphadenectomy with splenectomy in radical surgery for advanced (pT3/pT4) remnant gastric cancer
2016, Surgery (United States)Citation Excerpt :Conversely, the high frequency of hilar lymph node metastasis may help to explain the benefits of splenectomy in advanced remnant gastric cancer cases compared to proximal gastric cancer cases.5,18,26 Li et al27 reported that spleen-preserving lymphadenectomy was associated with a slightly better survival rate and relatively lower incidence of postoperative complications than those with splenectomy for advanced middle third gastric cancer. However, the value of spleen-preserving lymphadenectomy has not been clarified sufficiently.
Spleen plays a two-way role in cancer incidence and cancer progression
2022, Research SquareIs splenic hilar lymph node dissection necessary for proximal gastric cancer surgery?
2021, Annals of Gastroenterological Surgery